# FDA 483 - LifeSouth Community Blood Centers - October 26, 2023

Source: https://www.keypedia.com/records/483/lifesouth-community-blood-centers/c1060c92-40c2-45eb-b571-38d52ce3c901

> FDA 483 for LifeSouth Community Blood Centers on October 26, 2023. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: LifeSouth Community Blood Centers
- Inspection Date: 2023-10-26
- Product Type: biologics
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: LifeSouth Community Blood Centers in Palatka, FL, was inspected regarding its blood collection procedures. The inspection revealed that the firm failed to consistently follow its written standard operating procedures for registering blood donors, specifically regarding the use of legal names. This resulted in a donor being registered under a preferred name rather than their legal name for multiple donations.

## Related Officers

- [Investigator at U.S.FDA](https://www.keypedia.com/people/barbara-t-carmichael/4c451805-e327-450d-b2e5-48a40f6232fe)

Company: https://www.keypedia.com/companies/lifesouth-community-blood-centers/dd0a15c7-17f0-4748-9d2b-537ca08582ce

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6